Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06457139 · ClinicalTrials.gov registry record · NA
Preventing T2DM After GDM With Immediate Postpartum Screening
A NA study of Type 2 Diabetes and Gestational Diabetes, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT06457139: Recruiting NA study of Type 2 Diabetes and Gestational Diabetes, sponsored by University of Massachusetts, Worcester.
NCT06457139 is a NA study of Type 2 Diabetes and Gestational Diabetes that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 116 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06457139, a NA study of Type 2 Diabetes and Gestational Diabetes, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.
Primary Outcome
Detection of Type 2 Diabetes Mellitus by 2 hour oral glucose tolerance test
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Glucose tolerance test (2 hour)
- OTHER Active Comparator
Study Locations (1)
Massachusetts
- University of Massachusetts Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2028-12-01 |
| Phase | NA |
What NCT06457139 shows while recruiting
NCT06457139 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Glucose tolerance test (2 hour) is the first listed.
NCT06457139 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06457139 about?
NCT06457139 is a clinical study titled "Preventing T2DM After GDM With Immediate Postpartum Screening". The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.
What is the current status of trial NCT06457139?
This trial is currently recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2025-06-01. Estimated completion is 2028-12-01.
What conditions does trial NCT06457139 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Gestational Diabetes.
What interventions are being tested in trial NCT06457139?
The interventions under investigation include: Glucose tolerance test (2 hour) (DIAGNOSTIC_TEST), Active Comparator (OTHER).
Who is sponsoring clinical trial NCT06457139?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06457139 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06457139's enrollment target sits among peer trials
116 138th of 327 higher than 189 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI